Rafarma Pharmaceuticals, Inc. (RAFA)
OTCMKTS · Delayed Price · Currency is USD
0.0202
-0.0053 (-20.78%)
At close: Jun 30, 2026
Rafarma Pharmaceuticals Market Cap
Rafarma Pharmaceuticals has a market cap or net worth of $1.77 million as of July 6, 2026. Its market cap has decreased by -85.97% in one year.
Market Cap
1.77M
Enterprise Value
n/a
Revenue
133.33K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.02
Market Cap Chart
Since October 18, 2012, Rafarma Pharmaceuticals's market cap has decreased from 20.34M to 1.77M, a decrease of -91.28%. That is a compound annual growth rate of -16.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 1.77M | -26.34% |
| Dec 31, 2025 | 2.41M | -64.50% |
| Dec 31, 2024 | 6.78M | -70.44% |
| Dec 29, 2023 | 22.93M | -40.44% |
| Dec 30, 2022 | 38.51M | -47.44% |
| Dec 31, 2021 | 73.26M | -47.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trees | 2.31M |
| Redwood Scientific Technologies | 2.27M |
| Nutra Pharma | 2.15M |
| Nascent Pharma Holdings | 2.05M |
| Dakshidin Corporation | 1.77M |
| Anything Technologies Media | 1.70M |
| Procyon | 1.65M |
| CBD of Denver | 1.61M |